Navigation Links
PDI Reports 2011 Fourth Quarter and Year End Financial Results
Date:3/7/2012

pected to generate $48 million in revenue during 2012."

Ms. Lurker continued, "Looking ahead, we expect 2012 to be a year of continued execution for PDI as we pursue what has become a strong pipeline of business -- reflecting pharmaceutical companies' continued belief in the value of outsourcing their commercial infrastructure as a way to attain a much more flexible and cost-effective business model. Moving forward, we feel we are well positioned to take advantage of market opportunities."

Business Reviews - Continuing OperationsRevenue - For the fourth quarter of 2011, revenue of $38.3 million was 9% lower than the fourth quarter of 2010. The overall decrease is the result of lower Sales Services revenue.

  • Sales Services segment revenue for the fourth quarter of 2011 of $29.8 million was $11.6 million lower than the fourth quarter of 2010.  Contracts in place in 2010 that subsequently expired were only partially offset by new contracts.
  • Product Commercialization Services segment revenue for the fourth quarter of 2011 of $5.6 million is related to services under a new fee-for-service arrangement within the company's new Interpace BioPharma business unit.
  • Marketing Services segment revenue for the fourth quarter of 2011 of $2.9 million was $2.0 million higher than the fourth quarter of 2010 due to higher revenue for both Group DCA and PDI Voice.

  • Gross Profit - For the fourth quarter of 2011, gross profit of $8.7 million was 8% higher than the fourth quarter of 2010. The overall increase was driven by growth in revenues in Marketing Services and the new fee-for-service arrangement in Product Commercialization, partially offset by lower sales in Sales Services.

  • Sales Services segment gross profit for the fourth quarter of 2011 of $6.5 million was $2.2 million lower than the fourth quarter of 2010 primarily due to lower revenue.
  • Product Commercialization Services segment reported gr
    '/>"/>

  • SOURCE PDI, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results
    2. Cell Therapeutics, Inc. (CTI) Reports Fourth Quarter and Year-End Financial Results and Milestones
    3. Stereotaxis Reports 2011 Financial Results; Provides 2012 Milestones
    4. ZONARE Reports Fourth Quarter and 2011 Results
    5. IRIDEX Reports 2011 Fourth Quarter and Year-End Results
    6. Cumberland Pharmaceuticals Reports 2011 Annual Financial Results
    7. Nektar Therapeutics Reports Fourth Quarter and Year-End 2011 Financial Results
    8. Angeion Corporation Reports First Quarter Fiscal Year 2012 Operating Results
    9. ERT Reports Fourth Quarter and Full Year 2011 Operating Results
    10. Valeant Pharmaceuticals Reports 2011 Fourth Quarter Financial Results
    11. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2011 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, ... where its Phase I trial of Lixte,s lead compound, LB‑100, ... institutions. John S. Kovach , M.D., the ... was planned to be completed at a single site. Accrual ...
    (Date:1/23/2015)... CAPE TOWN, South Africa , Jan. 23, 2015 ... and distributor of personal protective equipment for all forms ... include the flagship Leatt-Brace® neck brace, announced today that ... minicross racing federation, now requires all riders to wear ...
    (Date:1/23/2015)... (NYSE: MNK ) announced today that its ... The open-ended authorization permits the company to repurchase up ... "Funding additional initiatives and seeking attractive business ... pursue a range of focused growth strategies," said ...
    Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
    ... Netsmart, the leading provider of clinical solutions ... announced that Dr. Dennis Morrison, a national  thought ... joined Netsmart as Chief Clinical Officer. ... will lead the Netsmart clinical team in transforming ...
    ... community leaders, health care professionals, and people of faith ... urged Express Scripts to get back to the ... largest pharmacy chain to return to its, network.  As ... for prescriptions filled at Walgreens and Duane Reade pharmacies. ...
    Cached Medicine Technology:Dr. Dennis Morrison Joins Netsmart as Chief Clinical Officer 2Dr. Dennis Morrison Joins Netsmart as Chief Clinical Officer 3Over 200 Community Leaders and Organizations Across the Nation Urge Express Scripts To Reach Agreement With Walgreens 2
    (Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved ... upcoming 32nd Annual Miami Breast Cancer Conference ... LLC (PER®) , shares that “a fast-growing, virulent” cancer ... she had not followed up her clean mammogram with ...
    (Date:1/22/2015)... La Jolla, Calif. (PRWEB) January 22, 2015 ... and Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen ... (CHI) for their leadership in advancing biotechnology, biomedical ... Mitchell, Bonilla and Olsen each received the “2014 ...
    (Date:1/22/2015)... Florida (PRWEB) January 22, 2015 IsoComforter, Inc. ... therapy machine with patented IsoTube design to treat specific body ... introduced the most progressive and easy to use patented cold ... post-operative and sports related orthopedic and muscle injuries. IsoComforter ...
    (Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
    (Date:1/22/2015)... As interest in the value of spiritual support as ... Rev. Eric J. Hall , president and CEO of the ... the keynote speaker on January 27 at an international summit ... The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual Care,” ...
    Breaking Medicine News(10 mins):Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
    ... 30 MedTrust Online LLC simultaneously announced today that ... a more powerful search engine for Oncology as a ... oncologist to its Advisory Board. With now ... becoming the leading source for cancer doctors to research ...
    ... Pharmaceuticals, a division of Wyeth (NYSE: WYE ... Clinical Oncology (ASCO) Cancer Foundation to help support its ... health information and conduct physician education programs. The ... of the American Society of Clinical Oncology in Orlando, ...
    ... surgery unnecessary in most cases, study finds , , ... longer the best treatment option for most patients ... other organs, a new study suggests. , Immediate ... IV metastatic colorectal cancer had previously been the ...
    ... Heart Failure (HF) syndrome either in stable chronic patients ... used to diagnose disease risk, to predict outcome and ... press conference at Heart Failure 2009 in Nice, France, ... Cardiology, presented these new findings, namely: , , ...
    ... 2 diabetes will continue to fuel an explosion in ... disease, according to John McMurray, professor of cardiology at ... Failure Association. He reported that around one-third of patients ... them the outlook is very serious. For doctors, he ...
    ... Milestone is Celebrated with the Crowning of the Skyscape "Millioneer" ... ... 30, 2009 -- Skyscape®, the worldwide leading service for ... milestone: the company,s user network has now reached over 1 ...
    Cached Medicine News:Health News:MedTrust Online Completes Second Round of Financing, Releases Next Generation Search Engine for Oncology Utilizing Dell eHealthcare Architecture Framework 2Health News:Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care 2Health News:Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care 3Health News:Chemo Alone Is Best for Advanced Colon Cancer 2Health News:Novel biomarkers in heart failure 2Health News:Obesity and diabetes double risk of HF -- patients with both conditions 'very difficult' to treat 2Health News:Skyscape's Mobile Healthcare Professional Community Crosses the 1 Million Mark 2Health News:Skyscape's Mobile Healthcare Professional Community Crosses the 1 Million Mark 3Health News:Skyscape's Mobile Healthcare Professional Community Crosses the 1 Million Mark 4
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: